• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070350-18
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Respiratory Failure (2484); Thrombosis/Thrombus (4440)
Event Date 02/10/2021
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.The reported patient effects of thrombosis and hypotension are listed in the xience xpedition everolimus eluting coronary stent systems instructions for use (ifu) as known patient effects of coronary procedures.As reportedly the stent was seen on the stent delivery system at the time of deployment, it is possible that interaction with the balloon/device during deflation and/or withdrawal resulted in the reported stent dislodgement; however this cannot be confirmed.The investigation determined a conclusive cause for the reported stent dislodgement cannot be determined.Additionally, the reported stent dislodgement possibly contributed to the reported patient effects; however a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatments appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the patient presented critically with acute coronary syndrome and an anterior wall myocardial infarction.During treatment of a mildly calcified, moderately tortuous, 80% stenosed, de novo lesion in the proximal left anterior descending(lad) coronary artery, intravascular ultrasound (ivus) noted a plaque rupture.After access to the vessel, a 3.5x18mm xience xpedition drug eluting stent (des) was advanced without issue and deployed; however, during deployment, the patient experienced sudden bradycardia, hypotension and went into cardiac arrest.The delivery system was removed and cardiopulmonary resuscitation (cpr) was successfully performed, reviving the patient.Angiography showed no flow to the lad, no cardiac activity in the left circumflex (lcx) and no stent in the lad or anywhere in the coronary.Cpr was continued, the patient intubated, a temporary pacemaker placed, and emergency medications were given to the patient.Thrombus aspiration was performed.Eventually, the patient was successfully resuscitated.Another 3.5x18mm xience xpedition des was then deployed at the target lesion and post dilated.Ivus showed a well deployed des from the lad to the lmca with no adverse patient sequela.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11638795
MDR Text Key245087131
Report Number2024168-2021-02938
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 04/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/03/2023
Device Catalogue Number1070350-18
Device Lot Number0022741
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-